Pharmacologic Inhibition of Tpl2 Blocks Inflammatory Responses in Primary Human Monocytes, Synoviocytes, and Blood
J. Perry Hall(Inflammation Research Foundation), Lih‐Ling Lin(Pfizer (United States))
Cited by 76
Related Papers
IRAK4 kinase activity controls Toll-like receptor–induced inflammation through the transcription factor IRF5 in primary human monocytes
|Journal of Biological Chemistry|2017|71